Britt Meelby Jensen

Elected in 2024 

Core capabilities

  • CEO, Ambu (2022-)
  • CEO, Atos Medical (2019-2022)
  • CEO, Zealand Pharma (2015-2019)
  • CEO, Dako (2013-2014)
  • Novo Nordisk, ending as Corporate VP, Global Marketing (2002-2013)
  • Management Consultant, McKinsey & Company (2000-2002)
  • Marketing Associate, PPU Maconomy (1998-2000)

Selected positions and directorships

  • Member of the Board of Directors of Hempel A/S (2024-)
  • Member of the Board of Trustees of the Hempel Foundation (2018-2024)
  • Member of the Board of Directors of Hempel Invest A/S (2018-2024)

Education

  • Cand. merc. International Marketing & Management, Copenhagen Business School (2000)
  • MBA, Economics, Solvay Business School i Bruxelles (1998)
LOADING